Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172024 · ClinicalTrials.gov registry record
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 15,172
- Enrollment target
NCT05172024 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 15,172 participants.
The verdict
NCT05172024 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 15,172 participants
- Enrollment target
Study Summary
This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without Post-Acute Sequelae of COVID-19 (PASC) symptoms will be followed to identify risk factors and occurrence of PASC. This study will be conducted in the United States and subjects will be recruited through inpatient, outpatient, and community-based settings. Study data including age, demographics, social determinants of health, medical history, vaccination history, details of acute SARS-CoV-2 infection, overall health and physical function, and PASC symptom screen will be reported by subjects or collected from the electronic health record using a case report form at specified intervals. Biologic specimens will be collected at specified intervals, with some tests performed in local clinical laboratories and others performed by centralized research centers or banked in the Biospecimen Repository. Advanced clinical examinations and radiologic examinations will be performed at local study sites with cross-site standardization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,172 participants |
| Start Date | 2021-10-29 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172024
The ClinicalTrials.gov registry entry for NCT05172024 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15,172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05172024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05172024 about?
NCT05172024 is a clinical study titled "Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)". This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without Post-Acute ...
What is the current status of trial NCT05172024?
This trial is currently completed. The enrollment target is 15,172 participants. The study started on 2021-10-29. Estimated completion is 2025-10-31.
Who is sponsoring clinical trial NCT05172024?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.